TipRanks
Go Ultimate55% OFF

Marker Therapeutics (MRKR) Stock Forecast & Price Target

609 Followers
See the Price Targets and Ratings of:

MRKR Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to Marker Therapeutics in the past 3 months

MRKR Stock 12 Month Forecast

$9.00▲(791.09% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Marker Therapeutics in the last 3 months. The average price target is $9.00 with a high forecast of $10.00 and a low forecast of $8.00. The average price target represents a 791.09% change from the last price of $1.01.
Highest Price Target$10.00Average Price Target$9.00Lowest Price Target$8.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for MRKR
Price TargetFollowArticle
Canaccord Genuity$8buy692.08%UpsideReiterated10/20/26
H.C. Wainwright$10buy890.10%UpsideReiterated09/21/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
SLDBSolid Biosciences
AHCOAdaptHealth
ONCBeOne Medicines
ARDXArdelyx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Marker Therapeutics

3 Months
John Newman
John NewmanCanaccord Genuity
Success Rate6/13 ratings generated profit
46%
Average Return
+5.69%

Copying John Newman's trades and holding each position for 3 Months would result in 46.15% of your transactions generating a profit, with an average return of +5.69% per trade.

1 Year
John Newman
John NewmanCanaccord Genuity
Success Rate3/13 ratings generated profit
23%
Average Return
-12.46%

Copying John Newman's trades and holding each position for 1 Year would result in 23.08% of your transactions generating a profit, with an average return of -12.46% per trade.

2 Years
John Newman
John NewmanCanaccord Genuity
Success Rate0/13 ratings generated profit
0%
Average Return
-26.52%

Copying John Newman's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -26.52% per trade.

MRKR Analyst Recommendation Trends

02468Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for MRKR
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy45552
Buy00000
Hold00000
Sell00000
Strong Sell00000
total45552

In the current month, MRKR has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MRKR average Analyst price target in the past 3 months is 9.00.

MRKR Financial Forecast

$-2$-1.5$-1$-0.5$0Q4 2025Q2 2026Q3 2026
High$-0.07
Consensus$-0.12
Low$-0.16

MRKR Earnings Forecast

Next quarter’s earnings estimate for MRKR is -$0.12 with a range of -$0.16 to -$0.07. The previous quarter’s EPS was -$0.09. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$1M$2.1M$3.2M$4.2MQ4 2025Q2 2026Q3 2026
High$4.2M
Consensus$2.12M
Low$700K

MRKR Sales Forecast

Next quarter’s sales forecast for MRKR is $2.12M with a range of $700.00K to $4.20M. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

MRKR Stock Forecast FAQ

What is MRKR’s average 12-month price target, according to analysts?
Based on analyst ratings, Marker Therapeutics’s 12-month average price target is $9.00.
What is MRKR’s upside potential, based on the analysts’ average price target?
Marker Therapeutics has 791.09% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MRKR a Buy, Sell or Hold?
Marker Therapeutics has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Marker Therapeutics’s price target?
The average price target for Marker Therapeutics is $9.00. This is based on 2 12-month price targets, issued in the past 3 months. The highest analyst price target is $10.00, the lowest forecast is $8.00. The average price target represents a 791.09% increase from the current price of $1.01.
What do analysts say about Marker Therapeutics?
Marker Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of MRKR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.